414 related articles for article (PubMed ID: 12451255)
1. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
Sawada T; Fuchinoue S; Teraoka S
Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
[TBL] [Abstract][Full Text] [Related]
2. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation.
Sawada T; Fuchinoue S; Kawase T; Kubota K; Teraoka S
Clin Transplant; 2004 Jun; 18(3):254-60. PubMed ID: 15142045
[TBL] [Abstract][Full Text] [Related]
3. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
4. Initial experience with ABO-incompatible live donor renal transplantation.
Tsai MK; Wu MH; Lo SC; Lai IR; Yu SC; Yuan RH; Lee PH
J Formos Med Assoc; 2006 Sep; 105(9):775-9. PubMed ID: 16959628
[TBL] [Abstract][Full Text] [Related]
5. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.
Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K
Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy.
Sonnenday CJ; Warren DS; Cooper M; Samaniego M; Haas M; King KE; Shirey RS; Simpkins CE; Montgomery RA
Am J Transplant; 2004 Aug; 4(8):1315-22. PubMed ID: 15268734
[TBL] [Abstract][Full Text] [Related]
7. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation.
Usuda M; Fujimori K; Koyamada N; Fukumori T; Sekiguchi S; Kawagishi N; Akamatsu Y; Enomoto Y; Satoh K; Satoh A; Ishida K; Moriya T; Satomi S
Transplantation; 2005 Jan; 79(1):12-6. PubMed ID: 15714163
[TBL] [Abstract][Full Text] [Related]
8. Immunization by blood-type antigen in human immunoglobulin products before ABO-incompatible kidney transplantation.
Sawada T; Ando T; Sato S; Kubota K; Fuchinoue S; Teraoka S
Clin Transplant; 2004 Apr; 18(2):219-21. PubMed ID: 15016140
[TBL] [Abstract][Full Text] [Related]
9. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
[TBL] [Abstract][Full Text] [Related]
10. A novel approach to successful ABO-incompatible high-titer renal transplantation.
Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T
Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213
[TBL] [Abstract][Full Text] [Related]
11. [An experience of ABO-incompatible kidney transplantation using plasmapheresis and anti-CD20 monoclonal antibody].
Moon HW; Yun YM; Hur M; Park JH; Lee HW; Chang SH; Yun IJ
Korean J Lab Med; 2009 Dec; 29(6):585-8. PubMed ID: 20046092
[TBL] [Abstract][Full Text] [Related]
12. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
13. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports.
Koshino K; Okamoto M; Sakai K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Okajima H; Yoshimura N
Transplant Proc; 2011; 43(6):2379-82. PubMed ID: 21839272
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
Han S; Hwang E; Park S; Park U; Kim H; Cho W
Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
[TBL] [Abstract][Full Text] [Related]
15. A case of nearly mistaken AB para-Bombay blood group donor transplanted to a group 'O' recipient.
Townamchai N; Watanaboonyongcharoen P; Chancharoenthana W; Avihingsanon Y
BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25362187
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
[TBL] [Abstract][Full Text] [Related]
17. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
[TBL] [Abstract][Full Text] [Related]
19. [A case of renal transplantation from an ABO-incompatible donor successfully pretreated with double filtration plasmapheresis].
Hirano Y; Ohira T; Ishikawa A; Ushiyama T; Suzuki K; Fujita K
Hinyokika Kiyo; 1996 Nov; 42(11):887-90. PubMed ID: 8973941
[TBL] [Abstract][Full Text] [Related]
20. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
